Company / Tangible Book Value per Share
TG Therapeutics, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$4.16
FY2025
5-year range
$0.40 / $4.16
FY2021-FY2025
Trend
+183.2%
vs FY2024
Sector context
#107 of 209
Health Care
What the data says
At $4.16, TG Therapeutics, Inc.'s tangible book value per share ranks #107 of 209 in the Health Care sector. Tangible Book Value per Share has increased for 3 consecutive years, from $0.40 in FY2022 to $4.16 in FY2025.
Based on SEC 10-K filings.
4.16 in FY2025 with a 5-year CAGR of -2.6%.
Improved from $1.09 to $4.16 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +117.6%
- 5-Year CAGR
- -2.6%
- 10-Year CAGR
- -
Sector benchmark
#107 of 209 in Health CareTop 51% of 209This company $4.16 Sector average $93.47
▼
-95.6% below sector average
Key checks
Key Insights
- TG Therapeutics, Inc.'s tangible book value per share has grown for 3 consecutive years.
- In FY2025, tangible book value per share increased 183.2% year-over-year.
- Ranks #107 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.16 | +183.2% |
| FY2024 | $1.47 | +34.6% |
| FY2023 | $1.09 | +170.4% |
| FY2022 | $0.40 | -76.0% |
| FY2021 | $1.68 | -64.5% |
| FY2020 | $4.74 | +500.7% |
| FY2019 | $0.79 | +148.4% |
| FY2018 | $0.32 | -70.2% |
| FY2017 | $1.07 | +49.1% |
| FY2016 | $0.72 | -67.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026